Why Iron Supplements Fail in Autoimmune Gastritis
At a Glance
Autoimmune gastritis destroys the stomach cells that produce acid, which is required to dissolve standard iron pills. Without stomach acid, oral iron sits in the gut causing severe pain instead of absorbing. IV iron or liposomal iron are better alternatives that bypass this issue.
If you have autoimmune gastritis (AIG) and have tried taking standard iron pills, you may have noticed that they cause severe stomach upset without actually raising your iron levels. This happens because standard oral iron supplements require stomach acid to be properly dissolved and absorbed. Autoimmune gastritis destroys the cells in your stomach that produce acid, a condition known as achlorhydria (the absence of stomach acid) [1][2]. Without acid, the iron remains trapped in your digestive tract, irritating your stomach lining instead of entering your bloodstream.
The Role of Stomach Acid in Iron Absorption
When you swallow a standard iron pill, like ferrous sulfate, it enters your stomach as a solid salt. For your body to absorb this iron, it must first be dissolved and kept in a chemical form your body can absorb [3][4]. Gastric acid is the key ingredient that makes this happen [1][2].
Doctors often advise taking iron with orange juice or Vitamin C to boost this acidic environment, but if your stomach produces no acid at all due to AIG, this trick is usually not enough to solve the problem. In autoimmune gastritis, your immune system mistakenly attacks the parietal cells in your stomach lining, which are the exact cells responsible for pumping out stomach acid. Because your stomach cannot produce enough acid, the breakdown of standard iron pills fails, leaving the iron unabsorbed [5][6]. This is why iron deficiency anemia is often one of the first signs of autoimmune gastritis and why it is notoriously stubborn, or “refractory,” to standard oral iron therapy [6][7][8].
Why Iron Pills Cause Stomach Upset
Since the iron cannot be properly absorbed, it simply sits in your gastrointestinal (GI) tract. This unabsorbed iron is highly reactive and causes a harsh chemical reaction that inflames and damages your stomach and intestinal lining [9][10][11].
This chemical irritation is what causes the classic side effects of oral iron, including severe nausea, cramping, and constipation [12][13]. In some cases, the unabsorbed iron can even deposit directly into the stomach tissues, a condition called gastric siderosis, which causes further mucosal damage and discomfort [14][15][16].
Why Intravenous (IV) Iron is the Preferred Treatment
Because the digestive system in a person with autoimmune gastritis cannot process standard iron pills, doctors usually recommend bypassing the stomach entirely. Intravenous (IV) iron therapy delivers iron directly into your bloodstream [17][18].
IV iron ensures a rapid, reliable increase in your iron levels because it does not rely on stomach acid for absorption [19][20]. It is also much better tolerated in patients with GI conditions, avoiding the nausea, cramping, and damage caused by oral pills trapped in the digestive tract [12][21][22].
IV iron is typically administered through a vein at an infusion center or hospital clinic. The process can take anywhere from a quick 15-minute injection to a slow drip over a few hours, depending on the formulation. While it safely bypasses the gut, IV iron does carry its own specific risks, such as potential allergic reactions, temporary flu-like symptoms (like joint aches), or drops in blood phosphorus levels, which your care team will monitor.
Alternative Oral Options
If IV iron is not immediately available or preferred, standard iron pills should generally be avoided. However, newer oral formulations like sucrosomial iron or liposomal iron may be an option. In these formulations, the iron is wrapped in a protective lipid (fat) layer. This allows the iron to bypass the normal, acid-dependent absorption pathway in the stomach and instead be absorbed intact further down in the intestines [3][4][23].
These advanced oral forms have shown better tolerability and effectiveness in patients with malabsorption issues [24][25]. While these are often available over-the-counter as dietary supplements, you should work closely with your doctor or a hematologist to ensure they are dosed correctly for your specific level of deficiency.
Common questions in this guide
Why do iron pills cause severe stomach pain if I have autoimmune gastritis?
What is the best way to treat iron deficiency with autoimmune gastritis?
Are there any oral iron supplements that work for autoimmune gastritis?
Can taking unabsorbed iron pills cause long-term stomach damage?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Am I a candidate for IV iron infusions given my autoimmune gastritis and lack of stomach acid?
- 2.If we proceed with IV iron, what specific type will be used, and what side effects should I watch out for during and after the infusion?
- 3.Would sucrosomial or liposomal iron be a viable oral alternative for me to try before moving to IV therapy?
- 4.Do my recent endoscopy results show any signs of gastric siderosis (iron deposits) from past oral iron use?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (25)
- 1
Common Pitfalls in the Management of Patients with Micronutrient Deficiency: Keep in Mind the Stomach.
Carabotti M, Annibale B, Lahner E
Nutrients 2021; (13(1)) doi:10.3390/nu13010208.
PMID: 33450823 - 2
Creating a Framework for Treating Autoimmune Gastritis-The Case for Replacing Lost Acid.
Taylor L, McCaddon A, Wolffenbuttel BHR
Nutrients 2024; (16(5)) doi:10.3390/nu16050662.
PMID: 38474790 - 3
Sucrosomial® Iron: An Updated Review of Its Clinical Efficacy for the Treatment of Iron Deficiency.
Gómez-Ramírez S, Brilli E, Tarantino G, et al.
Pharmaceuticals (Basel, Switzerland) 2023; (16(6)) doi:10.3390/ph16060847.
PMID: 37375794 - 4
Ex Vivo and in Vivo Study of Sucrosomial® Iron Intestinal Absorption and Bioavailability.
Fabiano A, Brilli E, Mattii L, et al.
International journal of molecular sciences 2018; (19(9)) doi:10.3390/ijms19092722.
PMID: 30213039 - 5
Risk factors of type 1 gastric neuroendocrine neoplasia in patients with chronic atrophic gastritis. A retrospective, multicentre study.
Campana D, Ravizza D, Ferolla P, et al.
Endocrine 2017; (56(3)):633-638 doi:10.1007/s12020-016-1099-y.
PMID: 27592118 - 6
Sex-Related Differences in the Diagnosis and Evolution of Parietal Cell Antibody-Positive Autoimmune Gastritis: A Large Single-Center Retrospective Cohort Study.
Fuentes-Valenzuela E, Blanco S, Escribano Cruz S, et al.
Diagnostics (Basel, Switzerland) 2026; (16(3)) doi:10.3390/diagnostics16030387.
PMID: 41681705 - 7
A Retrospective Study on Clinical Features of Autoimmune Gastritis: Impact of Age, Sex, and Autoimmune Thyroid Disease in China.
Wang X, Lu CJ, Ding Y, et al.
Gut and liver 2025; (19(4)):528-535 doi:10.5009/gnl240448.
PMID: 39943807 - 8
Autoimmune Gastritis in Children: A Rare Cause of Refractory Iron-Deficiency Anemia.
Lendínez-Jurado A, García-Ruiz A, Sastre-Domínguez MA, et al.
Reports (MDPI) 2026; (9(1)) doi:10.3390/reports9010053.
PMID: 41718303 - 9
Ascorbic acid attenuates antineoplastic drug 5-fluorouracil induced gastrointestinal toxicity in rats by modulating the expression of inflammatory mediators.
Al-Asmari AK, Khan AQ, Al-Qasim AM, Al-Yousef Y
Toxicology reports 2015; (2()):908-916 doi:10.1016/j.toxrep.2015.06.006.
PMID: 28962429 - 10
Mycophenolic Acid Induces the Intestinal Epithelial Barrier Damage through Mitochondrial ROS.
Deng Y, Zhang Z, Yang H, et al.
Oxidative medicine and cellular longevity 2022; (2022()):4195699 doi:10.1155/2022/4195699.
PMID: 35847589 - 11
Chronic exposure to zearalenone induces intestinal inflammation and oxidative injury in adult Drosophila melanogaster midgut.
Chen Z, Wang F, Zhang W, et al.
Ecotoxicology and environmental safety 2023; (251()):114555 doi:10.1016/j.ecoenv.2023.114555.
PMID: 36680988 - 12
Iron Deficiency in Women's Health: New Insights into Diagnosis and Treatment.
Moisidis-Tesch CM, Shulman LP
Advances in therapy 2022; (39(6)):2438-2451 doi:10.1007/s12325-022-02157-7.
PMID: 35488139 - 13
Case report: Rapid onset, ischemic-type gastritis after initiating oral iron supplementation.
Koch RM, Tchernodrinski S, Principe DR
Frontiers in medicine 2022; (9()):1010897 doi:10.3389/fmed.2022.1010897.
PMID: 36405603 - 14
Efficacy and safety of ferric citrate hydrate compared with sodium ferrous citrate in Japanese patients with iron deficiency anemia: a randomized, double-blind, phase 3 non-inferiority study.
Komatsu N, Arita K, Mitsui H, et al.
International journal of hematology 2021; (114(1)):8-17 doi:10.1007/s12185-021-03123-9.
PMID: 33719027 - 15
Iron-Related Pseudomelanosis Duodeni in a Patient with Gastrointestinal Bleeding: A Case Report.
Saleh S, Chebbo H, Karam K, El Hajj II
The American journal of case reports 2024; (25()):e945238 doi:10.12659/AJCR.945238.
PMID: 39390733 - 16
Iron pill induced gastritis causing severe anemia.
Motwani K, Rubin J, Yfantis H, Willard M
Clinical journal of gastroenterology 2020; (13(5)):732-735 doi:10.1007/s12328-020-01141-4.
PMID: 32468501 - 17
Efficacy of oral vs. intravenous iron for the treatment of iron deficiency anemia in different conditions: A systematic review and meta-analysis.
Zhao C, He W
Biomedical reports 2026; (24(1)):11 doi:10.3892/br.2025.2084.
PMID: 41282507 - 18
Management of Iron-Deficiency Anemia in Inflammatory Bowel Disease: A Systematic Review.
Nielsen OH, Ainsworth M, Coskun M, Weiss G
Medicine 2015; (94(23)):e963 doi:10.1097/MD.0000000000000963.
PMID: 26061331 - 19
Comparing the Treatment Outcomes of Oral and Injectable Iron Therapies for Anemia in Pregnancy: A Meta-Analysis.
Qayyum J, Farhan SQ, Qureshi QUA, et al.
Cureus 2025; (17(2)):e78326 doi:10.7759/cureus.78326.
PMID: 40034615 - 20
Intravenous iron therapy in pediatrics: who should get it and when is the right time?
Cohen CT, Powers JM
Hematology. American Society of Hematology. Education Program 2023; (2023(1)):630-635 doi:10.1182/hematology.2023000496.
PMID: 38066925 - 21
Oral versus intravenous iron therapy in iron deficiency anemia: An observational study.
Das SN, Devi A, Mohanta BB, et al.
Journal of family medicine and primary care 2020; (9(7)):3619-3622 doi:10.4103/jfmpc.jfmpc_559_20.
PMID: 33102339 - 22
Intravenous iron infusions in pediatric patients: A retrospective review of efficacy and safety.
Strachan C, Kugler E, Devgan K, et al.
Journal of investigative medicine : the official publication of the American Federation for Clinical Research 2024; (72(5)):457-464 doi:10.1177/10815589241238219.
PMID: 38429647 - 23
Sucrosomial® Iron: A New Generation Iron for Improving Oral Supplementation.
Gómez-Ramírez S, Brilli E, Tarantino G, Muñoz M
Pharmaceuticals (Basel, Switzerland) 2018; (11(4)) doi:10.3390/ph11040097.
PMID: 30287781 - 24
Comparative evaluation of different oral iron salts in the management of iron deficiency anemia.
Suva MA, Tirgar PR
Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences 2024; (32(2)):485-494 doi:10.1007/s40199-024-00517-y.
PMID: 38740692 - 25
Sucrosomial Iron Supplementation in Anemic Patients with Celiac Disease Not Tolerating Oral Ferrous Sulfate: A Prospective Study.
Elli L, Ferretti F, Branchi F, et al.
Nutrients 2018; (10(3)) doi:10.3390/nu10030330.
PMID: 29522446
This page provides educational information about iron absorption and autoimmune gastritis. Always consult your gastroenterologist or hematologist before starting or changing iron supplements or IV therapy.
Get notified when new evidence is published on autoimmune gastritis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.